Using AI to improve breast cancer screening in Östergötland
The Use of Artificial Intelligence (AI) to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland
This study is testing if using artificial intelligence in breast cancer screening can help doctors find cancer more accurately and make their jobs easier in Östergötland, Sweden.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60000 (estimated) |
| Ages | 40 Years to 74 Years |
| Sex | Female |
| Sponsor | Ostergotland County Council, Sweden Academic / other |
| Locations | 1 site (Linköping, Östergötland) |
| Trial ID | NCT06187350 on ClinicalTrials.gov |
What this trial studies
This project investigates the implementation of artificial intelligence (AI) in breast cancer screening with mammography in Östergötland, Sweden. The aim is to enhance diagnostic safety by increasing the sensitivity and specificity of mammography, thereby reducing the incidence of interval cancers and the workload for radiologists. The study will monitor performance metrics such as cancer detection rates and reading times for radiologists when using AI decision support. No specific interventions will be assigned to participants, as the focus is on observing the effects of AI in routine clinical practice.
Who should consider this trial
Good fit: Ideal candidates are women participating in the regular Breast Cancer Screening Program in Region Östergötland.
Not a fit: Patients with breast implants or symptoms of suspected breast cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier detection of breast cancer and a more efficient screening process.
How similar studies have performed: Previous studies have shown promise in using AI for breast cancer screening, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Women participating in the regular Breast Cancer Screening Program in Region Östergötland Exclusion Criteria: Women with breast implants or other foreign implants in the mammogram Women with symptoms or signs of suspected breast cancer
Where this trial is running
Linköping, Östergötland
- Region Östergötland — Linköping, Östergötland, Sweden (Recruiting)
Study contacts
- Principal investigator: Håkan Gustafsson, Ph.D. — Region Östergötland
- Study coordinator: Håkan Gustafsson, Ph.D.
- Email: hakan.l.gustafsson@liu.se
- Phone: +46101043023
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.